Identification in the NK1 tachykinin receptor of a domain involved in recognition of neurokinin A and septide but not of substance P

FEBS Letters

Volumn 447, Issue 2-3, 1999, Pages 155-159

  Wijkhuisen, Anne ^a,b   Sagot, Marie Astrid ^a   Frobert, Yveline ^a   Créminon, Christophe ^a   Grassi, Jacques ^a   Boquet, Didier ^a   Couraud, Jean Yves ^a,b  

^a DIF   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Hydropathic complementarity; Neurokinin A; NK1 receptor; Septide; Substance P; Tachykinin

Indexed keywords

NEUROKININ 1 RECEPTOR; NEUROKININ A; NEUROKININ B; PHOSPHATIDYLINOSITOL; SEPTIDE; SUBSTANCE P; TACHYKININ;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CELL STRAIN COS1; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; POINT MUTATION; PRIORITY JOURNAL; RECEPTOR AFFINITY;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BINDING SITES; CERCOPITHECUS AETHIOPS; COS CELLS; DNA, COMPLEMENTARY; HUMANS; MOLECULAR SEQUENCE DATA; NEUROKININ A; PEPTIDE FRAGMENTS; POINT MUTATION; PYRROLIDONECARBOXYLIC ACID; RECEPTORS, NEUROKININ-1; RECOMBINANT PROTEINS; SUBSTANCE P; TACHYKININS;

MAMMALIA;

EID: 0032971471     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(99)00298-7     Document Type: Article

References (32)

1. Regoli D., Boudon A., Fauchere J.L. Pharmacol. Rev. 46:1994;551-599.
2. Gerard N.P., Bao L., Xioa-Ping H., Gerard C. Regul. Pept. 43:1993;21-35.
3. Maggi C.A., Schwartz T.N. Trends Pharmacol. Sci. 18:1997;351-354.
4. Yanagisawa M., Otsuka M. Br. J. Pharmacol. 100:1990;711-716.
5. Maggi C.A., Patachini R., Quartara L., Rovero P., Santicioli P. Eur. J. Pharmacol. 197:1991;167-174.
6. Otsuka M., Yoshioka K. Physiol. Rev. 73:1993;229-307.
7. Sagan S., Chassaing G., Pradier L., Lavielle S. J. Pharm. Exp. Ther. 276:1996;1039-1048.
8. Hastrup H., Schwartz T.W. FEBS Lett. 399:1996;264-266.
9. Bost K.L., Blalock J.E. Methods Enzymol. 168:1989;16-28.
10. Baranyi L., Campbell W., Ohshima K., Fujimoto S., Boros M., Pkada H. Nature Med. 1:1995;894-901.
11. Hanin V., Déry O., Boquet D., Sagot M.A., Créminon C., Couraud J.Y., Grassi J. Mol. Immunol. 34:1997;829-838.
12. Fassina G., Melli M. ImmunoMethods. 5:1994;114-120.
13. Martins V.R., Graner E., Garcia-Abreu J., De Souza S.J., Mercadantf A.F., Veiga S.S., Zanata S.M., Neto V.M., Brentani R.R. Nature Med. 3:1997;1376-1382.
14. Wormser U., Laufer R., Hart Y., Chorev M., Gilon C., Selinger Z. EMBO J. 5:1986;2805-2808.
15. Pradier L., Ménager J., Le Guern J., Bock M.D., Heuillet E., Fardin V., Garret C., Doble A., Mayaux J.F. Mol. Pharmacol. 45:1994;287-293.
16. Glowinski J. Trends Pharmacol. Sci. 16:1995;365-367.
17. Boquet D., Déry O., Frobert Y., Grassi J., Couraud J.Y. Mol. Immunol. 32:1995;303-308.
18. Hoebeke J. Médecine/Sciences. 12:1995;1661-1667.
19. McGuigan J.E. ImmunoMethods. 5:1994;158-166.
20. Fong T.M., Yu H., Huang R.R.C., Strader C.D. Biochemistry. 31:1992;11806-11811.
21. Fong T.M., Huang R.R.C., Strader C.D. J. Biol. Chem. 267:1992;25664-25667.
22. Gether U., Johansen T.E., Snider R.M., Lowe J.A., Edmonds-Alt X., Yokota Y., Nakanishi S., Schwartz T.W. Regul. Pept. 46:1993;49-58.
23. Tian Y., Wu L.H., Pu Y., Huang C.C., Chung F.Z. J. Neurochem. 67:1996;1191-1199.
24. Huleux C., Berthier A., Rossignol B., Dreux C. J. Neurochem. 70:1998;858-864.
25. Maggi C.A., Patacchini R., Meini S., Guiliani S. Eur. J. Pharmacol. 235:1993;309-311.
26. Gether U., Johansen T.E., Snider R.M., Lowe III J.A., Nakanishi S., Schwartz T.W. Nature. 362:1993;345-348.
27. Elling C.E., Nielsen S.M., Schwartz T.W. Nature. 374:1995;74-77.
28. Sagan S., Beaujouan J.C., Torrens Y., Saffroy M., Chassaing G., Glowinski J., Lavielle S. Mol. Pharmacol. 52:1997;120-127.
29. Colquhoun D. Br. J. Pharmacol. 125:1998;924-947.
30. Ciucci A., Palma C., Manzini S., Werge T.M. Br. J. Pharmacol. 125:1998;393-401.
31. Yokota Y., Akazawa C., Ohkubo H., Nakanishi S. EMBO J. 11:1992;3585-3591.
32. Boyd N.D., Kage R., Dumas J.J., Krause J.E., Leeman S.E. Proc. Natl. Acad. Sci. USA. 93:1996;433-437.